Literature DB >> 1267158

Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometry.

S L Malcolm, T R Marten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267158     DOI: 10.1021/ac60370a045

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


× No keyword cloud information.
  8 in total

1.  GC-MS determination of guanidinoacetate in urine and plasma.

Authors:  D H Hunneman; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

2.  Why hypertensive patients vary in their response to oral debrisoquine.

Authors:  J H Silas; M S Lennard; G T Tucker; A J Smith; S L Malcolm; T R Marten
Journal:  Br Med J       Date:  1977-02-12

3.  Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neurone.

Authors:  J H Silas; G T Tucker; A J Smith; N R Fieller
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.

Authors:  D S Davies; G C Kahn; S Murray; M J Brodie; A R Boobis
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

5.  The disposition of debrisoquine in hypertensive patients.

Authors:  J H Silas; M S Lennard; G T Tucker; A J Smith; S L Malcolm; T R Marten
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

6.  Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Authors:  C J Speirs; S Murray; D S Davies; A F Biola Mabadeje; A R Boobis
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

7.  Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients.

Authors:  J H Silas; J Jones; G T Tucker; M M Townshend; C A Phillips; A J Smith
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver.

Authors:  G C Kahn; A R Boobis; S Murray; M J Brodie; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.